Skip to main content
Clinical Trials/NCT00699569
NCT00699569UnknownNot Applicable

The Effect of Hyperimmune Colostrum on Radiation-Induce Oral Mucositis of Patients With Head and Neck Cancer

Tel-Aviv Sourasky Medical Center1 site in 1 country30 target enrollmentStarted: July 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Locations
1

Study Overview

Brief Summary

To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer.

Exclusion Criteria

  • •Other tumors
  • •Non-epithelial tumors
  • •Pregnancy
  • •Poor functional status

Arms & Interventions

1

Experimental

Patients receiving active investigational product

Intervention: hyperimmune colostrum (Dietary Supplement)

2

Placebo Comparator

Patients receiving Placebo

Intervention: Placebo (Dietary Supplement)

Investigators

Sponsor Class
Other Gov

Study Sites (1)

Loading locations...

Similar Trials